Tracy J. Mayne, PhD, DaVita Inc., Denver discusses his study on that found focused phosphorus management program decreases hyperphosphataemia in end stage renal disease patients.
Restless legs syndrome (RLS) increases the risk of new cardiovascular events and cardiovascular mortality among patients with end-stage renal disease (ESRD), according to Italian researchers.
Researchers in Taiwan have linked consumption two herbal products—Guan Mu Tong (Aristolochia manshuriensis) or Guang Fangchi (Aristolochia fangchi)—to an increased risk of developing end-stage renal disease (ESRD).
No guidelines for managing the general diabetic paient have targeted the diabetic kidney patient.
Cardiovascular events are twice as likely to occur in highly fatigued patients, recent study shows.
As this issue goes to press, thousands of rescue personnel from the United States and other countries throughout the world are engaged in relief efforts in earthquake-ravaged Haiti, where the death toll exceeded 100,000.
Sickle cell trait (HbAS) is twice as prevalent among African Americans with end-stage renal disease (ESRD) than in the general African-American population, data show.
The incidence of treatment for end-stage renal disease (ESRD) in people with diabetes continues to decline, a trend that could be related to improved treatment and care and a decrease in the prevalence of ESRD risk factors, according to a recently published study.
High levels of immunoglobulin M (IgM) in the urine of diabetic patients may predict development of end-stage renal disease (ESRD) and death from cardiovascular disease (CVD), independent of albuminuria, a small study suggests.
A pilot study showed that megastrol may help improve weight and ability to exercise in dialysis patients, according to a report in the Journal of Renal Nutrition (2009; published online ahead of print).
